Concepedia

Updated Results of a Global Phase II Study with Crizotinib in Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC)

D. Kim, Myung‐Ju Ahn, Pan‐Chyr Yang, Xuan Liu, Tommaso De Pas, Lucio Crinò, Silvana Lanzalone, Anna Polli, Alice T. Shaw

Annals of Oncology · 2012 · 71 citations · 1 references

DOIFull text

Open access

Concepts

References

1

Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with <i>ALK-</i>positive non-small cell lung cancer (NSCLC).

D. Ross Camidge, Yung‐Jue Bang, E.L. Kwak et al. · Journal of Clinical Oncology · 2011 · 135 citations

, , +14